Multiple myeloma is a cancer of the bone marrow plasma cells. It is synonymous with "myeloma" and "plasma cell myeloma." Plasma cells make antibodies against infectious agents such as viruses and bacteria. A cancerous or malignant plasma cell is called a myeloma cell. Myeloma is called “multiple” because there are frequently multiple patches or areas in bone marrow where it grows.
click on the image above to watch the teleconference
(to view the teleconference in fullscreen, click on the bottom right square icon beside the YouTube logo)
Learn more about current trends in myeloma treatment and research with this update from three major medical meetings held in June 2015. Dr. Brian G.M. Durie will explain what's new and exciting from the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA), and the International Myeloma Working Group Summit (IMWG).
This teleconference is sponsored by an educational grant from:
Amgen, Bristol-Myers Squibb, Celgene Corporation, Janssen, and Takeda Oncology